Skip to main content

User account menu

  • Log in

Languages

  • English
  • Français
  • Português
  • Español
  • العربية
  • Pусский

Main navigation

  • About ISSUP

    • ISSUP Rationale
    • Membership
      • Membership Criteria
      • Code of Ethics
      • Who is ISSUP for?
    • News
    • International Partners
    • Governance
    • ISSUP Scientific Council
    • Friends of ISSUP (USA)
    • ISSUP Workshops
      • Bali 2025
      • Thessaloniki 2024
      • Buenos Aires 2023
      • Manila 2022
      • Abu Dhabi 2022
      • International Conference 2021 (Virtual)
      • Africa 2020 (Virtual)
      • Vienna 2019
      • Nairobi 2018
      • Cancún 2017
      • Campinas 2016
      • Bangkok 2015
    • ISSUP Awards
      • Evidence-Based Award
      • Local Initiative Award
      • Services Award
      • Excellence in Training Provision
      • Outstanding Contribution to ISSUP Award
    • In Memoriam
    • Acknowledgements
    • ISSUP Website Guides
    • Contact ISSUP
    • FAQs - Frequently Asked Questions
  • Professional Development

    • Online Learning Hub
      • How to Register
      • UTC Self Led Courses
    • Universal Curricula (UC)
      • Universal Prevention Curriculum
      • Universal Treatment Curriculum
      • Universal Recovery Curriculum
      • Access UPC & UTC
      • Training Providers
      • Becoming a Training Provider
      • Global Training Program
    • Resources
      • Glossary
      • ISSUP Webinars
      • ICAP certification
      • INEP Plus
      • Prevention Insights Video Series
      • Prevention Lists
      • HealthEKnowledge
      • WiRED International
      • Quality in Treatment
      • SPR-ISSUP Prevention Workbook
    • Job Board
  • Knowledge Share

    • Search in the Knowledge Share
    • ADDICTOLOGY Journal
      • Latest Issue
  • National Chapters

    • Africa
      • ISSUP Botswana
      • ISSUP Côte d’Ivoire
      • ISSUP Egypt
      • ISSUP The Gambia
      • ISSUP Kenya
      • ISSUP Namibia
      • ISSUP Nigeria
      • ISSUP South Africa
      • ISSUP Tanzania
      • ISSUP Togo
      • ISSUP Uganda
    • The Americas
      • ISSUP Argentina
      • ISSUP The Bahamas
      • ISSUP Brazil
      • ISSUP Canada
      • ISSUP Chile
      • ISSUP Colombia
      • ISSUP Ecuador
      • ISSUP El Salvador
      • ISSUP Guatemala
      • ISSUP Mexico
      • ISSUP Panama
      • ISSUP Paraguay
      • ISSUP Peru
      • ISSUP United States
    • Asia
      • ISSUP Afghanistan
      • ISSUP India
      • ISSUP Indonesia
      • ISSUP Kazakhstan
      • ISSUP Lebanon
      • ISSUP Malaysia
      • ISSUP in Pakistan
      • ISSUP Philippines
      • ISSUP Qatar
      • ISSUP Sri Lanka
      • ISSUP Thailand
      • ISSUP Türkiye
      • ISSUP United Arab Emirates
      • ISSUP Uzbekistan
      • ISSUP Vietnam
    • Europe
      • ISSUP Czech Republic
      • ISSUP Greece
      • ISSUP Italy
      • ISSUP Spain
      • ISSUP Ukraine
      • ISSUP United Kingdom
    • How to Become a National Chapter
    • ISSUP National Chapters' Advisory Committee
  • Events

    • Search through all events
  • Networks

    • A–Z
  • My ISSUP

    • Member Directory
    • Apply for membership

Tx

Treatment / Tratamiento
DiscussionsFilesImagesVideosLinksEventsKnowledge ShareAll
Jose Luis Vazquez Martinez

Understanding the risks of mixing drugs

Jose Luis Vazquez Martinez - 26 May 2023
February 17, 2022 Mixing drugs, also known as polysubstance use, occurs when two or more drugs are taken together or within a short time period, intentionally or unintentionally. Even if someone has mixed drugs before, or mixes drugs often, the body can react differently every time. Whether it’s...
  • Read more about Understanding the risks of mixing drugs
  • Add new comment
Jose Luis Vazquez Martinez

Datos sobre el uso de múltiples sustancias

Jose Luis Vazquez Martinez - 26 Mayo 2023
Fuente: https://www.cdc.gov/stopoverdose/polysubstance-use/pdf/Spanish-Polysubstance-Factsheet-508.pdf ¿Qué es el uso de múltiples sustancias? El uso de más de una droga, lo que se conoce como uso de múltiples sustancias, es frecuente. Esto incluye cuando se toman dos o más drogas al mismo tiempo o...
Datos sobre el uso de múltiples sustancias CDC.pdf
  • Read more about Datos sobre el uso de múltiples sustancias
  • Add new comment
Jose Luis Vazquez Martinez

Polysubstance Use Facts

Jose Luis Vazquez Martinez - 26 May 2023
Source: https://www.cdc.gov/stopoverdose/polysubstance-use/pdf/Polysubstance-Use-Fact-Sheet_508.pdf What is polysubstance use? The use of more than one drug, also known as polysubstance use, is common. This includes when two or more are taken together or within a short time period, either...
Polysubstance Use Fact Sheet CDC.pdf
  • Read more about Polysubstance Use Facts
  • Add new comment
Jose Luis Vazquez Martinez

Estándar Mexicano de Competencias de la Consejería en Adicciones

Jose Luis Vazquez Martinez - 24 Mayo 2023
El objetivo del Estándar es establecer las competencias básicas e indispensables en el ejercicio de la consejería en adicciones en nuestro país, principalmente las que se ejercen en establecimientos con modalidad residencial y que sirven de referente para el proceso de evaluación. Está integrado por...
Estándar Mexicano de Compentencias de la Consejería en Adicciones.pdf
  • Read more about Estándar Mexicano de Competencias de la Consejería en Adicciones
  • Add new comment
Jose Luis Vazquez Martinez

La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides

Jose Luis Vazquez Martinez - 24 Mayo 2023

Fuente: https://www.fda.gov/news-events/press-announcements/la-fda-aprueba-una-nueva-opcion-de-tratamiento-con-buprenorfina-para-el-trastorno-por-consumo-de

 

Para publicación inmediata: 24 de mayo del 2023

Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi (buprenorfina) de liberación prolongada para tratar el trastorno por consumo de opioides (OUD, por sus siglas en inglés) de moderado a grave. Brixadi está disponible en dos formulaciones, una inyección semanal...

  • Read more about La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
  • Add new comment
Jose Luis Vazquez Martinez

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder

Jose Luis Vazquez Martinez - 24 May 2023

Source: https://www.fda.gov/news-events/press-announcements/fda-approves-new-buprenorphine-treatment-option-opioid-use-disorder

 

For Immediate Release: May 23, 2023

Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two formulations, a weekly injection that can be used in patients who have started treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with buprenorphine, and...

  • Read more about FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
  • Add new comment
Jose Luis Vazquez Martinez

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes

Jose Luis Vazquez Martinez - 22 May 2023
Source: Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes. JAMA Netw Open. 2023;6(5):e2314328. doi:10.1001/jamanetworkopen.2023.14328 Key Points Question Did rates of methadone dispensing for opioid use...
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes_1.pdf
  • Read more about Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
  • Add new comment
Jose Luis Vazquez Martinez

Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

Jose Luis Vazquez Martinez - 22 May 2023
Source: Jakubowski, A., Singh-Tan, S., Torres-Lockhart, K. et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract 18, 31 (2023). https://doi.org/10.1186/s13722-023-00386-x Abstract...
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder opportunities for training innovation.pdf
  • Read more about Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation
  • Add new comment
Jose Luis Vazquez Martinez

Enfoques prácticos hacia el policonsumo de sustancias

Jose Luis Vazquez Martinez - 21 May 2023
Martes 14 de marzo del 2023, 09:10 – 10:00 (hora de Washington, DC, E.E.U.U.) PROGRAMA Palabras de apertura Embajador Adam Namm, Secretario Ejecutivo, Comisión Interamericana para el Control del Abuso de Drogas (CICAD/OEA) Embajador Darío Ernesto Chirú Ochoa, Embajador de Panamá en Viena y...
Translations
Español
العربية
  • Read more about Enfoques prácticos hacia el policonsumo de sustancias
  • Add new comment
Rasha Abi Hana

Psychoactive Prescription Drug Abuse: Selected Psychological Symptoms and Quality of Life in Addiction Treatment. Study Protocol

Shared by Rasha Abi Hana - 30 March 2023
Format
Scientific article
Published by / Citation
Rychlá, K., & Šťastná, L. (2022). Psychoactive prescription drug abuse: Selected psychological symptoms and quality of life in addiction treatment. Study protocol. Adiktologie, 22(4), 258–263. https://doi.org/10.35198/01-2022-004-0002

BACKGROUND: The abuse of psychoactive prescription drugs has become increasingly common in the Czech Republic. These drugs include sedatives, hypnotics, anxiolytics (benzodiazepines and Z-hypnotics), and opioids. Patients with an addiction to these prescription drugs exhibit symptoms associated with long-term use, particularly psychological and somatic problems, sleep disturbances, impaired cognitive functioning, and irritability. There is a need for a flexible response to their needs.

AIMS: The aim of the research is to describe selected psychological symptoms and the quality of life of...

AddictologyIssue 4/2022
Translations
Português
العربية
Pashto
Urdu
  • Read more about Psychoactive Prescription Drug Abuse: Selected Psychological Symptoms and Quality of Life in Addiction Treatment. Study Protocol
  • Add new comment
Rasha Abi Hana

Bion’s Basic Assumption Groups in the Regimen Treatment of Addictions: Clinical Implications

Shared by Rasha Abi Hana - 30 March 2023
Format
Scientific article
Published by / Citation
Riegel, K. D. (2022). Bion’s basic assumption groups in the regimen treatment of addictions: Clinical implications. Adiktologie, 22(4), 250–256. https://doi.org/10.35198/01-2022-004-0004

This article provides reflection on the potential application of Bion’s model of basic assumption groups in patients undergoing midterm inpatient addiction treatment. The clinical implications are discussed in terms of the usability of Bion’s model and its possible benefits for patients in regimen addiction treatment, as well as the pitfalls associated with its application in this treatment modality. Despite the highly theoretical nature of this model, clinical experience to date confirms that analysis of the underlying assumptions and associated protomental patterns can provide valuable...

AddictologyIssue 4/2022
Translations
Español
  • Read more about Bion’s Basic Assumption Groups in the Regimen Treatment of Addictions: Clinical Implications
  • Add new comment
Jose Luis Vazquez Martinez

Prevalence of Mental Illness and Mental Health Care Use Among Police Officers

Jose Luis Vazquez Martinez - 26 February 2023
Source: Jetelina KK, Molsberry RJ, Gonzalez JR, Beauchamp AM, Hall T. Prevalence of Mental Illness and Mental Health Care Use Among Police Officers. JAMA Netw Open. 2020;3(10):e2019658. doi:10.1001/jamanetworkopen.2020.19658 Key Points Question What is the prevalence of mental illness and mental...
Prevalence of Mental Illness and Mental Health Care Use Among Police Officers_0.pdf
  • Read more about Prevalence of Mental Illness and Mental Health Care Use Among Police Officers
  • Add new comment
Jose Luis Vazquez Martinez

Intervención breve vinculada a ASSIST para el consumo riesgoso y nocivo de sustancias: manual para uso en la atención primaria

Jose Luis Vazquez Martinez - 12 Febrero 2023
Fuente: Organización Mundial de la Salud & Organización Panamericana de la Salud. (‎2011)‎. Intervención breve vinculada a ASSIST para el consumo riesgoso y nocivo de sustancias: manual para uso en la atención primaria. Organización Panamericana de la Salud. Este manual acompaña al documento La...
Intervención breve vinculada a ASSIST para el consumo riesgoso y nocivo de sustancias manual para uso en la atención primaria.pdf
  • Read more about Intervención breve vinculada a ASSIST para el consumo riesgoso y nocivo de sustancias: manual para uso en la atención primaria
  • Add new comment
Jose Luis Vazquez Martinez

Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department

Jose Luis Vazquez Martinez - 6 February 2023
Source: Ware, O. D., Buresh, M. E., Irvin, N. A., Stitzer, M. L., & Sweeney, M. M. (2022). Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department. Drug and alcohol dependence reports, 5, 100093. Highlights •The emergency department...
Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department_1.pdf
  • Read more about Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department
  • Add new comment
Jose Luis Vazquez Martinez

Community mental health funding, stakeholder engagement and outcomes: a realist synthesis

Jose Luis Vazquez Martinez - 3 February 2023
Source: Duncan A, Stergiopoulos V, Dainty KN, et al. Community mental health funding, stakeholder engagement and outcomes: a realist synthesis. BMJ Open 2023;13:e063994. doi: 10.1136/bmjopen-2022-063994 Abstract Mental health services continues to be a high priority for healthcare and social service...
Community mental health funding, stakeholder engagement and outcomes a realist synthesis.pdf
  • Read more about Community mental health funding, stakeholder engagement and outcomes: a realist synthesis
  • Add new comment
Jose Luis Vazquez Martinez

Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders

Jose Luis Vazquez Martinez - 2 February 2023
Source: Fleury, MJ., Cao, Z., Grenier, G. et al. Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders. Subst Abuse Treat Prev Policy 18, 5 (2023). https://doi.org/10.1186/s13011-022...
Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders.pdf
  • Read more about Profiles of quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes among patients with substance-related disorders
  • Add new comment
Jose Luis Vazquez Martinez

Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review

Jose Luis Vazquez Martinez - 26 January 2023
Source: Shapiro, C. J., Watson MacDonell, K., & Moran, M. (2021). Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review. Implementation Research and Practice. https://doi.org/10.1177/2633489520988258 Plain language abstract: Provider self-efficacy is known...
Provider self-efficacy in delivering evidence-based psychosocial interventions A scoping review_0.pdf
  • Read more about Provider self-efficacy in delivering evidence-based psychosocial interventions: A scoping review
  • Add new comment
Jose Luis Vazquez Martinez

Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada. Versión 2.0

Jose Luis Vazquez Martinez - 21 Enero 2023
Los trastornos mentales, neurológicos y por consumo de sustancias (MNS) son muy frecuentes y representan una gran carga de enfermedad y discapacidad a nivel mundial. Subsiste una amplia brecha entre la capacidad de los sistemas de salud y los recursos disponibles, entre lo que se necesita...
mhGAP 2.0 español.pdf
  • Read more about Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada. Versión 2.0
  • Add new comment
Jose Luis Vazquez Martinez

Increasing the Uptake of Effective Addiction Health Services via Dissemination and Implementation Science

Jose Luis Vazquez Martinez - 17 January 2023
Presenter: Sara Becker, Northwestern University This presentation will describe a program of research focused on increasing the uptake of effective health services for persons with or at risk of substance use disorders. At the end of the presentation, attendees will be able to: (a) define key...
  • Read more about Increasing the Uptake of Effective Addiction Health Services via Dissemination and Implementation Science
  • Add new comment
Jose Luis Vazquez Martinez

Soporte y redes frente a las agresiones sexuales facilitadas por drogas en contextos de ocio juvenil

Jose Luis Vazquez Martinez - 27 Diciembre 2022
Soporte y redes internacionales frente a las agresiones sexuales facilitadas por drogas en contextos de ocio juvenil. Universidad de Alcalá. Fundación General Universidad
  • Read more about Soporte y redes frente a las agresiones sexuales facilitadas por drogas en contextos de ocio juvenil
  • Add new comment

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • …
  • Next page ››
  • Last page Last »

Upcoming Events

There aren't any upcoming events
All Events
Contact Us

Stay Connected

Newsletter

ISSUP is funded by the U.S. Department of State via the Bureau of International Narcotics and Law Enforcement Affairs (INL). INL works to keep Americans safe by countering crime, illegal drugs, and instability abroad.

Copyright © International Society of Substance Use Prevention and Treatment Professionals Privacy Policy